Covered Call Analyzer Aggressive "STOCKS-TO-CONSIDER"
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
Oct Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
| Interactive Corp | IACI | $23.52 | 400 | $9,428 | QTHJE | $0.90 | $340 | 25 | 10% | +$32 | 0% |
| Comments: |
Not called. Sold Nov25 at 0.35. Not called. Holding. Sold all shares at $23.84 to close out position. |
||||||||||
| Sandisk | SNDK | $26.24 | 300 | $7,892 | SWQJY | $1.05 | $295 | 27.5 | 8% | ($970) | -12% |
| Comments: |
Exercised get-out price at $22.30 after buying back calls at 0.21. |
||||||||||
| Pan American Silver | PAAS | $14.23 | 700 | $9,981 | USPJC | $0.45 | $295 | 15 | 8% | +$814 | +8% |
| Comments: |
Called. |
||||||||||
| Andrew Corp. | ANDW | $11.90 | 800 | $9,540 | AQNJV | $0.40 | $300 | 12.5 | 8% | +$760 | +8% |
| Comments: |
Called. |
||||||||||
| Juniper Networks | JNPR | $24.14 | 400 | $9,676 | JUXJE | $0.90 | $340 | 25 | 7% | +$964 | +10% |
| Comments: |
Not called. Sold Nov25 at 0.80. Called. |
||||||||||
| Mylan Labratories | MYL | $19.46 | 500 | $9,750 | MYLJD | $0.80 | $380 | 20 | 6% | ($590) | -6% |
| Comments: |
Not called. sold all shares at $17.52 to close out position. |
||||||||||
| Advanced Micro Cevices | AMD | $12.70 | 700 | $8,910 | AMDJO | $0.55 | $365 | 13 | 6% | +$555 | +6% |
| Comments: |
Called. |
||||||||||
| Business Objects S.A. | BOBJ | $21.99 | 400 | $8,816 | BBQJX | $0.85 | $320 | 22.5 | 6% | +$504 | +6% |
| Comments: |
Called. |
||||||||||
| Gold Fields LTD | GFI | $12.16 | 800 | $9,748 | GFIJV | $0.40 | $300 | 12.5 | 6% | +$552 | +6% |
| Comments: |
Called. |
||||||||||
| Peoplesoft, Inc. | PSFT | $19.62 | 500 | $9,830 | PQOJD | $0.65 | $305 | 20 | 5% | +$475 | +5% |
| Comments: |
Called. |
||||||||||
|
All positions closed out with value us +$3,097. |
|||||||||||
*After the effect of all commissions.
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.